An update of epigenetic drugs for the treatment of cancers and brain diseases: a comprehensive review

Z Sahafnejad, S Ramazi, A Allahverdi - Genes, 2023 - mdpi.com
Epigenetics has long been recognized as a significant field in biology and is defined as the
investigation of any alteration in gene expression patterns that is not attributed to changes in …

Epigenetics in human disease and prospects for epigenetic therapy

G Egger, G Liang, A Aparicio, PA Jones - Nature, 2004 - nature.com
Epigenetic mechanisms, which involve DNA and histone modifications, result in the
heritable silencing of genes without a change in their coding sequence. The study of human …

Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden

ML Stone, KB Chiappinelli, H Li, LM Murphy… - Proceedings of the …, 2017 - pnas.org
Ovarian cancer is the most lethal of all gynecological cancers, and there is an urgent unmet
need to develop new therapies. Epithelial ovarian cancer (EOC) is characterized by an …

Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells

HC Tsai, H Li, L Van Neste, Y Cai, C Robert… - Cancer cell, 2012 - cell.com
Reversal of promoter DNA hypermethylation and associated gene silencing is an attractive
cancer therapy approach. The DNA methylation inhibitors decitabine and azacitidine are …

5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy

JK Christman - Oncogene, 2002 - nature.com
Azacytidine was first synthesized almost 40 years ago. It was demonstrated to have a wide
range of anti-metabolic activities when tested against cultured cancer cells and to be an …

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

D Lodygin, V Tarasov, A Epanchintsev, C Berking… - Cell cycle, 2008 - Taylor & Francis
Recently, we and others identified the microRNA miR-34a as a target of the tumor
suppressor gene product p53. Ectopic miR-34a induces a G1 cell cycle arrest, senescence …

UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma

R Mudbhary, Y Hoshida, Y Chernyavskaya, V Jacob… - Cancer cell, 2014 - cell.com
Ubiquitin-like with PHD and RING finger domains 1 (UHRF1) is an essential regulator of
DNA methylation that is highly expressed in many cancers. Here, we use transgenic …

Vitamin C increases viral mimicry induced by 5-aza-2′-deoxycytidine

M Liu, H Ohtani, W Zhou, AD Ørskov, J Charlet… - Proceedings of the …, 2016 - pnas.org
Vitamin C deficiency is found in patients with cancer and might complicate various therapy
paradigms. Here we show how this deficiency may influence the use of DNA …

Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism

H Gali-Muhtasib, M Diab-Assaf… - International …, 2004 - spandidos-publications.com
For centuries, the black seed (Nigella sativa) herb and oil have been used in Asia, Middle
East and Africa to promote health and fight disease. Thymoquinone (TQ), the most abundant …

The comet assay: a sensitive method for detecting DNA damage in individual cells

W Liao, MA McNutt, WG Zhu - Methods, 2009 - Elsevier
The comet assay is a sensitive and rapid method for DNA strand break detection in
individual cells, and the year 2009 represents the 25th anniversary of the first description of …